| Code | Description | Claims | Beneficiaries | Total Paid |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,951 |
1,783 |
$533K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,329 |
2,168 |
$520K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,081 |
1,995 |
$397K |
| 80053 |
Comprehensive metabolic panel |
6,053 |
5,198 |
$133K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
957 |
949 |
$112K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,696 |
2,375 |
$97K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,681 |
4,727 |
$66K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
295 |
280 |
$45K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,009 |
1,695 |
$38K |
| 71045 |
Radiologic examination, chest; single view |
1,129 |
985 |
$35K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
791 |
729 |
$33K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
298 |
277 |
$32K |
| 70450 |
Computed tomography, head or brain; without contrast material |
180 |
169 |
$30K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,772 |
1,650 |
$26K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,093 |
956 |
$24K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,369 |
1,250 |
$24K |
| 81001 |
|
2,975 |
2,760 |
$24K |
| 71046 |
Radiologic examination, chest; 2 views |
386 |
373 |
$21K |
| 80061 |
Lipid panel |
1,070 |
1,046 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
467 |
442 |
$19K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
42 |
40 |
$18K |
| 84484 |
|
1,133 |
919 |
$18K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
591 |
587 |
$17K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
672 |
619 |
$16K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,635 |
1,435 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
660 |
361 |
$15K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
55 |
53 |
$14K |
| 80050 |
General health panel |
163 |
159 |
$14K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,230 |
948 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
807 |
787 |
$13K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
924 |
792 |
$12K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
177 |
176 |
$9K |
| 85610 |
|
2,055 |
1,804 |
$9K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
68 |
68 |
$9K |
| 83690 |
|
805 |
733 |
$9K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,146 |
1,080 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,357 |
1,238 |
$8K |
| 85027 |
|
1,479 |
1,231 |
$7K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,012 |
912 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
348 |
297 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
159 |
143 |
$7K |
| 83880 |
|
207 |
189 |
$6K |
| 86403 |
|
267 |
260 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
578 |
567 |
$6K |
| 85730 |
|
1,253 |
1,118 |
$6K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
82 |
80 |
$5K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,721 |
1,201 |
$5K |
| J3490 |
Unclassified drugs |
750 |
291 |
$5K |
| 83735 |
|
556 |
405 |
$4K |
| 84703 |
|
255 |
242 |
$4K |
| 76641 |
|
41 |
26 |
$4K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
70 |
67 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
450 |
300 |
$4K |
| 0002A |
|
116 |
116 |
$4K |
| 73130 |
|
36 |
36 |
$4K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
595 |
452 |
$3K |
| 81025 |
|
311 |
297 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
372 |
332 |
$3K |
| 0001A |
|
128 |
126 |
$3K |
| 77080 |
|
51 |
49 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13 |
12 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
30 |
27 |
$2K |
| 82962 |
|
2,110 |
1,058 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
100 |
98 |
$2K |
| 83605 |
|
123 |
106 |
$2K |
| 84439 |
|
134 |
131 |
$2K |
| 73610 |
|
13 |
13 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
620 |
556 |
$2K |
| 87420 |
|
27 |
27 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
1,517 |
1,421 |
$2K |
| 82150 |
|
109 |
108 |
$1K |
| 87077 |
|
175 |
164 |
$1K |
| 87186 |
|
83 |
78 |
$1K |
| 82947 |
|
15 |
15 |
$915.61 |
| 36415 |
Collection of venous blood by venipuncture |
59 |
58 |
$823.46 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
78 |
70 |
$700.80 |
| J0137 |
Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg |
15 |
12 |
$687.55 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
13 |
13 |
$536.60 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
611 |
535 |
$454.86 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,011 |
1,765 |
$414.40 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
25 |
25 |
$372.87 |
| A9270 |
Non-covered item or service |
732 |
485 |
$251.80 |
| 87806 |
|
25 |
24 |
$227.56 |
| S0028 |
Injection, famotidine, 20 mg |
60 |
51 |
$204.65 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
38 |
32 |
$181.55 |
| 86140 |
|
13 |
12 |
$50.55 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
13 |
13 |
$37.45 |
| 85652 |
|
14 |
13 |
$26.38 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
44 |
39 |
$17.20 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
23 |
18 |
$0.00 |